Mosanna Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mosanna Therapeutics, Inc. - overview
Established
2022
Location
Redwood City, CA, US
Primary Industry
Biotechnology
About
Founded in 2022 and based in California, US, Mosanna Therapeutics AG is a biotech company that operates as a manufacturer of therapeutic devices used for treating patients experiencing metabolic obstructive sleep apnea. In June 2025, Mosanna Therapeutics raised USD 80 million in series A funding co-led by new investors Pivotal Life Sciences and EQT Life Sciences, with participation from other new investors Forbion, Broadview Ventures, and Norwest Venture Partners. Returning investors Forty51 Ventures, High-Tech Gruenderfonds, and Supermoon Capital also participated in the round. The company offers a precision medicine approach that improves patient outcomes and quality of life in diseases with high unmet needs.
The firm is developing MOS-118 (formerly known as AVE0118), an advanced small molecule for metabolic obstructive sleep apnea (MOSA), a condition associated with adverse cardiovascular events and poor health outcomes. The company will use the June 2025 funding for the advancement of MOS118 through its Phase 2 clinical trials.
Current Investors
Forty51 Ventures, High-Tech Gruenderfonds, Supermoon Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.mosanna.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Mosanna Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.